Numinus to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023 | Psychedelic Invest

Numinus Wellness Inc. (TSX: NUMI / OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will present at the Healthcare Virtual Conference presented by Maxim Group LLC and hosted by M-Vest, on June 20-22, 2023.

Payton Nyquvest, Founder and CEO of Numinus, will participate in a Mental Health Care Clinics panel discussion on Wednesday, June 21, 2023 at 10:00 am ET / 7:00 am PT. In addition, Mr. Nyquvest will participate in a Numinus-focused Fireside Chat at 11:00 a.m. ET / 8:00 a.m. PT on Thursday, June 22, 2023.

This conference will be live on M-Vest. To attend, sign up to become an M-Vest member and register here.

For more information about the conference, or to schedule a one-on-one meeting with Numinus’ management, please email invest@numinus.com.

About Numinus

Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental healthcare and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.